Epithalon is a synthetic peptide based on research from Russian ageing science, theorised to influence telomerase activity and the pineal gland. It is marketed within longevity circles specifically for its proposed anti-ageing and lifespan effects.
The foundational research is largely from a specific body of Russian-language studies, including some animal work suggesting effects on telomerase and lifespan in specific models. This research has not been widely replicated or validated by the broader international scientific community, and independent, high-quality human trials are lacking.
Unverified purity and dosing as an unregulated research chemical. The core claims (telomerase activation, lifespan extension) are exactly the kind of mechanism where unintended effects, including theoretical cancer risk from altering telomerase activity, deserve real caution rather than enthusiasm.
Legal and research status: this peptide is typically sold as a research chemical, labelled not for human consumption, and is not an approved medicine or supplement in the UK, EU or US. Buying it for personal use sits in a legal grey area, and product purity and dosing are not independently verified or regulated. The claims made for Epithalon significantly outpace independently validated human evidence. Given the specific mechanism claimed (telomerase activity), this warrants particular caution rather than casual use.
Sold online as a research chemical, priced per vial.
Published research on Epithalon, largely from a specific research lineage, not independently replicated at scale internationally. Educational information only. Not an approved medicine.